FDA & IARC on Sidelines of Talcum Powder Cancer Lawsuit News
The U.S. Food and Drug Administration and the International Agency for Research on Cancer have both largely stayed out of talcum powder ovarian cancer lawsuit news and stopped short of identifying a definitive connection between talcum powder and ovarian cancer, though both published statements that leaves open the possibility for a link to be substantial.
Monday, February 15, 2016 - A pair of giant health and drug agencies, the U.S. Food and Drug Administration (FDA) and the International Agency for Research on Cancer (IARC), have taken standoffish stances on the connection between talcum powder and an increased risk of ovarian cancer. With neither institution wanting to makes waves in the talcum powder ovarian cancer lawsuit news world, the onus has fallen to the legitimacy of research studies and internal Johnson & Johnson investigations for plaintiffs to bring serious charges against the health care manufacturer regarding their talcum powder products.
The IARC has claimed that while the agency believes that talc is “possibly carcinogenic to humans” based on the perineal genital use of the talcum powder products in human studies, but hasn’t declared a definitive stance as to the research that has been released focused on the ovarian cancer issue. A number of studies have determined that there is a significant increase in the risk of contracting ovarian cancer when women use talcum powder genitally on a regular basis. Some studies have estimates that the risk of contracting ovarian cancer can jump by as much as 35 percent as a result of using talcum powder regularly.
These studies have also failed to elicit a hard-line stance from the FDA. Though the FDA does not prioritize the regulation of cosmetic products, it did list on its website that it is aware of the talcum powder ovarian cancer research that has been conducted for decades and states that concerning talcum powder’s connection to ovarian cancer, “these studies have not conclusively demonstrated such a link.” Neither the FDA or the IARC has made a declaration that talcum powder has no connection to ovarian cancer however, and both could be following talcum powder cancer lawsuit news to inform their future judgments on the danger posed by talcum powder products.
In the home state of talcum powder manufacturer and main defendant Johnson & Johnson (J&J), 103 talcum lawsuits were consolidated before a single federal judge in New Jersey in November. The current number has grown to 130 lawsuits in multicounty litigation as of January 23. The plaintiffs have not been able to bring much institutional evidence from either the FDA or the IARC because of their hands-off approach to the issue, though the substantial number of talcum powder research studies have bolstered the plaintiffs’ arguments against J&J. There are currently over 1,000 lawsuits in America making talcum powder ovarian cancer lawsuit news as they continue to grow nationwide.
The plaintiffs in the lawsuits claim that a definitive link between talcum powder and an increased risk in the contraction of ovarian cancer has been established based on dozens of research studies that have been conducted into the issue since 1971. J&J is also facing claims that the health care company was aware of these studies and the dangers that talcum powder could pose to consumers, but elected against affixing warnings to its products in an effort to protect the marketability of their talcum powder products. The lawsuits have been filed all around the country, with talcum powder cancer lawsuit news spreading as word of the possible connection between talcum powder and ovarian cancer spreads.
No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder
The Onder Law Firm
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.